• Osteopathic Manipulative Therapy In Patients With Headache- Systematic Literature Review

    Oct 1, 2017, 00:00

  • Potential Savings Achieved Through Switching COPD Patients from ICS-Containing Regimens to LAMA-LABA- A Dutch Perspective

    Oct 1, 2017, 00:00

  • USO De Los Índices De Shannon En La Evaluación Del Poder Discriminante Del EQ-5D Y EL EQ-5D-5L En UNA Muestra De Pacientes Con VIH/SIDA En Colombia

    Oct 1, 2017, 00:00

  • The Effect Of Nsaids On Myocardial, Vascular And Renal Risk Categories-Systematic Review Of Randomized Controlled Trial And Observational Studies

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Sorafenib Versus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma from Health Care System Perspective in Egypt

    Oct 1, 2017, 00:00

  • Polypharmacy And Interactions - What Is A Pharmacist Role?

    Oct 1, 2017, 00:00

  • Análisis De Variabilidad En Los Precios De Servicios En Salud Para Colombia

    Oct 1, 2017, 00:00

  • Regional Variations In Appraisal And Uptake Of New Treatments For Ultra Rare Diseases In The UK- A Case Study Of Ataluren For Nonsense Mutation Duchenne Muscular Dystrophy (NMDMD)

    Oct 1, 2017, 00:00

  • Assessment of Marketed and In-Development Products for Alzheimer’s Disease- What are the Strategic Value Drivers?

    Oct 1, 2017, 00:00

  • Estimation of Indirect Costs of The Children Viral Acute Intestinal Infections Therapy in Ukraine

    Oct 1, 2017, 00:00

  • Implementation Of A Societal Cost-Effective Model Of A Swiss Canton School Vaccination Campaign Through A Hospital Pharmacy Logistics Platform

    Oct 1, 2017, 00:00

  • Incidence and Prevalence of Epilepsy in Germany

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Pcv13 Vs Ppsv23 For The Immunization of Adults Over 65 Years with Low or Moderate Risk of Pneumococcal Infection

    Oct 1, 2017, 00:00

  • “Appraising the appraisers”- Do National Health Technology Assessment Agencies (NICE, GBA/IQWIG) Follow Their Official Evaluation Criteria?

    Oct 1, 2017, 00:00

  • The Patient-Reported Disease Burden In Adults With Atopic Dermatitis- A Cross-Sectional Study In Canada and Europe

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Posaconazole in Private and Public Brazilian Hospitals

    Oct 1, 2017, 00:00

  • O Indicative Budget Impact Of Posaconazole Versus Itraconazole In Invasive Fungal Infection Prophylaxis In Adult Patients With Aml/Mds

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness Of Screening For Severe Combined Immunodeficiency (SCID) In The UK NHS Newborn Bloodspot Screening Programme

    Oct 1, 2017, 00:00

  • The Evolution of Nice Medtech Innovation Briefings And Their Associated Technologies

    Oct 1, 2017, 00:00

  • Assessing The Robustness Of Network Meta-Analysis Of Atypical Antipsychotics In The Presence Of Heterogeneity

    Oct 1, 2017, 00:00

  • The Italian Answer To Prep Topic- Evidence From A Multi-Centre HTA Study

    Oct 1, 2017, 00:00

  • Association Of Multiple Chronic Conditions With Health-Related Quality Of Life And Physical Functioning

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan In The Treatment Of Chronic Heart Failure With Reduced Ejection Fraction In Turkey

    Oct 1, 2017, 00:00

  • Development And Psychometric Evaluation Of An Owner-Completed Measure Of Feline Health And Quality Of Life

    Oct 1, 2017, 00:00

  • Comparison of Early Scientific Advice Processes In UK, France And Germany (HTA ONLY)- Tips And Tricks

    Oct 1, 2017, 00:00

  • Bisphosphonates for Osteoporosis Treatment- A Cost-Effectiveness Analysis in Vietnamese Woman

    Oct 1, 2017, 00:00

  • Modeling Techniques for Fitting Healthcare Resource Use Costs Derived From Patient Reported Counts of Hospital, ER, And PCP Visits

    Oct 1, 2017, 00:00

  • Terms Requiring Multiple Translations Or A Descriptive Translation In The Target Language And Vice Versa

    Oct 1, 2017, 00:00

  • Glycemic Control of Adult Type 2 Diabetes Mellitus Patients In The Netherlands- A Cross-Sectional Real World Database Study

    Oct 1, 2017, 00:00

  • Relapsing-Remitting Multiple Sclerosis Patients On Dimethyl Fumarate Reported Less Physical And Psychological Disease Impact In The Real World Compared With Patients On Platform Therapies

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Neonatal Screening For Congenital Hypothyroidism

    Oct 1, 2017, 00:00

  • Pharmacoepidemiology of Lateral Amiotrophic Sclerosis in the Republic of Belarus

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Selexipag For The Treatment Of Pulmonary Arterial Hypertension (PAH) In Greece

    Oct 1, 2017, 00:00

  • Reevaluating A 10 Year Cost-Effectiveness Analysis (CEA) Of The Diabetes Prevention Program Outcomes Study (DPP/DPPOS)- Clarifying The Previous Confusion

    Oct 1, 2017, 00:00

  • Factors Associated with an Adherence with Antiepileptic Drugs in Children Treated in Pediatric Practices in Germany

    Oct 1, 2017, 00:00

  • Tofacitinib in Adult Patients with Active Rheumatoid Arthritis- Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Conceptual Model and Instrument Review in Multiple Sclerosis

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis (CUA) of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in the Brazilian Early Breast Cancer Patients

    Oct 1, 2017, 00:00

  • A Retrospective Database Analysis of Treatment Pathways And Estimated Costs of Treatment In Metastatic Colorectal Carcinoma (MCRC) In Germany

    Oct 1, 2017, 00:00

  • Do EU5 Countries with Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?

    Oct 1, 2017, 00:00

  • Evaluation Of Health-Related Quality Of Life Among Malaysian Non Dialysis Dependent Chronic Kidney Disease Patients

    Oct 1, 2017, 00:00

  • Economic Evaluation of Dasatinib Compared To Nilotinib as Second Line Treatment of Chronic Myeloid Leukemia in Greece

    Oct 1, 2017, 00:00

  • The Difference Between Regulatory And Market Access Decisions On Treatment Availability For New Drugs In Six Common Cancers Across Australia, Canada, And Europe

    Oct 1, 2017, 00:00

  • Assessing The Utilization Of Diabetic Non-Small Cell Lung Cancer Patients Compared To Non-Small Cell Lung Cancer Patients

    Oct 1, 2017, 00:00

  • Does the Distance to the Nearest Pharmacy Affect Medication Adherence Rates Among Elderly Patients with Diabetes?

    Oct 1, 2017, 00:00

  • Hospital Resource Use in Metastatic Castration Resistant Prostate Cancer (MCRPC) in National University Hospitals in Japan

    Oct 1, 2017, 00:00

  • Access To Medicines- Developing An Indicator To Assess The Impact of Public Policies

    Oct 1, 2017, 00:00

  • Identifying The Primary Outcome For A Randomised Controlled Trial In Rheumatoid Arthritis- The Role of A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany- A Population-Based Modelling Study

    Oct 1, 2017, 00:00

  • Cost Impact of A Novel Prophylactic Treatment For Haemophilia A Patients With Inhibitors In The UK

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Ivabradine In The Treatment of Patients With Chronic Heart Failure In Iran

    Oct 1, 2017, 00:00

  • Why Do People Participate In Health-Related Preference Studies? A Discrete-Choice Experiment

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Using Temocillin, A Narrow-Spectrum Antibiotic, As An Alternative To Broad-Spectrum Carbapenems

    Oct 1, 2017, 00:00

  • The Relationship of Quality of Life and Complete Psoriasis Clearance Over Time – Analyses From Brodalumab Trial Datasets

    Oct 1, 2017, 00:00

  • Avanços Do Monitoramento Do Horizonte Tecnológico No Brasil

    Oct 1, 2017, 00:00

  • Pricing Regulation For Generics In Gree The Case Of Atorvastatin

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis Of Transcatheter Aortic Valve Implantation In France

    Oct 1, 2017, 00:00

  • Impact of Ocrelizumab Vs. Interferon Beta-1a In Delaying The Deterioration Of Patients' Daily Functions and Associated Costs In Relapsing-Remitting Multiple Sclerosis

    Oct 1, 2017, 00:00

  • Predicting Quality Adjusted Life Years Using St. George Respiratory Results In Patients With Severe Emphysema Treated with Endobronchial Coils In Addition To Standard of Care Compared To Standard of Care Alone

    Oct 1, 2017, 00:00

  • Investigation Of Drug Therapy Problems In Type 2 Diabetes Outpatients With Comorbid Hypertension In A Tertiary Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • The Implications of Vaccine Characteristics and Private-Sector Vaccination on Varicella; A Model-Based Analysis for Mexico

    Oct 1, 2017, 00:00

  • Influence of Peer Pressure Mechanism on Quality and Costs of Healthcare, on Examples of Israel, France and USA

    Oct 1, 2017, 00:00

  • A Comparative Review of Value Assessment Frameworks In Germany, France, England, Australia, and South Korea- An Industry Perspective

    Oct 1, 2017, 00:00

  • Clinical Characteristics and Outcome of The Influenza A (H1N1) Patients Admitted to the Tertiary Level Hospital, Peshawar

    Oct 1, 2017, 00:00

  • Treatment Patterns for RA Patients in Italian Real Practice

    Oct 1, 2017, 00:00

  • Important Group Differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) in Patients with Metastatic Renal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Treatment Patterns In Head Neck Squamous Cell Cancer In Fran Artiste Study on Cancerology Patient Charts

    Oct 1, 2017, 00:00

  • Report of Low Density Lipoprotein (LDL) Levels in Patients Diagnosed Whit Hipertension, Diabetes Mellitus and Chronic Kidney Disease in Colombian Population

    Oct 1, 2017, 00:00

  • The Potential Value Of Multiparametric Magnetic Resonance Imaging In Active Surveillance Of Men With Low-Risk Prostate Cancer- A Cost-Effectiveness Modeling Study

    Oct 1, 2017, 00:00

  • A Validation Study of The Rank-Preserving Structural Failure Time Model- Confidence Intervals, Unique, Multiple and Erroneous Solutions

    Oct 1, 2017, 00:00

  • Avaliação Da Redução De Rehospitalização Dos Pacientes Com Esquizofrenia, Tratados com Palmitato De Paliperidona

    Oct 1, 2017, 00:00

  • Using Convergent Mixed Methods To Evaluate Treatment Risks and Benefits In Rare Disease- An Example From A Phase Ii Registration Trial In Metastatic Merkel Cell Carcinoma

    Oct 1, 2017, 00:00

  • Mapping the Modified Ashworth Scale and Physician’s Global Assessment to Preference-Based Health Utilities in Adults with Lower Limb Spasticity

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Two Long-Acting Muscarinic Antagonists For Copd Treatment In Spain- Umeclidinium VS. Tiotropium (HO-17-18472)

    Oct 1, 2017, 00:00

  • Lifelong Apixaban Treatment Is Cost-Effective For The Prevention of Venous Thromboembolism In The Netherlands

    Oct 1, 2017, 00:00

  • Analysis of Effectiveness Criteria In Pharmacoeconomic Studies of Antimicrobial Therapeutic Agents Proposed for Inclusion In The Essential Drug List (RUSSIA) In 2014-2016

    Oct 1, 2017, 00:00

  • Cost-Benefit Analysis of A Smoking Cessation Program Funded By The Spanish National System In Pre-Operative Patients

    Oct 1, 2017, 00:00

  • The Most Common Occupational Illnesses Of Medical- And Sports Masseurs

    Oct 1, 2017, 00:00

  • Cost Per Response for Abatacept Compared with Adalimumab In the Treatment of Patients with Rheumatoid Arthritis Based on Anti-Citrullinated Protein Antibody Titres In Italy

    Oct 1, 2017, 00:00

  • Economic Burden of Immune Thrombocytopenia (ITP) In Patients Receiving Eltrombopag (EPAG) And Romiplostim (ROMI)- Real World Evidence From 26 US Institutions

    Oct 1, 2017, 00:00

  • Specificities of Cancer Immunotherapy – Challenges From Market Access Perspective

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis (CEA) of Nivolumab in 2nd Line Non-Small Cell Lung Cancer (NSCLC) with Non-Squamous Histology (NSQ) Using A Mixed Comparator of Docetaxel and Pemetrexed in An Australian Setting

    Oct 1, 2017, 00:00

  • Comparative Efficacy And Safety of Olaparib 400 Mg Capsules Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients with Platinum-Sensitive Relapsed Non-Germline BRCA-Mutated Ovarian Cancer (P ...

    Oct 1, 2017, 00:00

  • Challenges In Demonstrating Disease-Modifying Effects- Evidence-Based Testing Of A Novel Statistical Approach In Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Delayed Biologic Switching Among Ankylosing Spondylitis (As) Patients May Result in Poor Health- Related Quality of Life- Results From A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Pink October in the Social Media- Are We Still (MIS)Guiding the Public?

    Oct 1, 2017, 00:00

  • Observed Reduction of Healthcare Utilization after Omalizumab Initiation Among Patients with Persistent Asthma Followed in Canadian Clinical Settings

    Oct 1, 2017, 00:00

  • Clinical And Cost Impact of A Novel Non-Invasive Approach For The Treatment of Cervical Dysplasia From A US Payer Perspective

    Oct 1, 2017, 00:00

  • Identifying Attributes of Cancer Treatments- What Do Stakeholders Consider Important?

    Oct 1, 2017, 00:00

  • Costo-Efectividad Del Tratamiento De La Artritis Reumatoide (Ar) Temprana- Una Revisión Sistemática

    Oct 1, 2017, 00:00

  • Short-Term Direct And Indirect Cost Burden of Cardiovascular Events In Patients With A History of Atherosclerotic Cardiovascular Disease In The US

    Oct 1, 2017, 00:00

  • Title- Modelling The Effect of Syphilis Screening At The Entry Point in Chilean Prisons

    Oct 1, 2017, 00:00

  • Health Related Quality OF Life Standards in Patients with Parkinson

    Oct 1, 2017, 00:00

  • Impact of Disease Activity Measures and Patient Characteristics on Health Utilities in RMS

    Oct 1, 2017, 00:00

  • Cost Consequence of Introducing Paliperidone Palmitate 3-Monthly For The Maintenance Treatment of Schizophrenia In The English National Health Service (NHS)

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And “No Intervention” In Switzerland

    Oct 1, 2017, 00:00

  • A Review of Clinical Outcome Assessment Labeling in Europe and in the United States (2013-2016)

    Oct 1, 2017, 00:00

  • Risk Sharing Agreements As Payment Mechanisms- A Comprehensive And Communicable Practical Approach For Stakeholders

    Oct 1, 2017, 00:00

  • The Study On Expression of Ap-1 Signaling Pathway and Polymorphisms Of Sep15 and Trxr-2 Genes In Kashin-Beck Disease

    Oct 1, 2017, 00:00

  • IS TRANSTHEORETICAL MODEL’S STAGES OF CHANGE A GOOD PREDICTOR OF MEDICATION ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES?

    Oct 1, 2017, 00:00

  • Real-World Treatment Patterns in Stage IV Non-Squamous Non-Small Cell Lung Cancer in Argentina

    Oct 1, 2017, 00:00

  • Psychological Impact of Cancer- More Good than Bad

    Oct 1, 2017, 00:00

  • Single Armed Observational Data To Closing The Gap In Otherwise Disconnected Evidence Networks

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparins for Venous Thromboembolism Prevention Following Total Knee Replacement- Comparative Effectiveness and Medical Costs from a French Nationwide Cohort Study of Around 60,000 Patie ...

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Physical Activity Promotion Intervention For People With Disabilities- A Markov Model Approach

    Oct 1, 2017, 00:00

  • Transition From Orphan Disease To Full Assessment In The German Amnog System- Key Learnings From Pioneers

    Oct 1, 2017, 00:00

  • Effects of Low Salt Diet on Gene Expression in Dog Heart

    Oct 1, 2017, 00:00

  • The Changing Trend of Cardiovascular Disease And Its Clinical Characteristics In Ethiopia-Hospital-Based Observational Study

    Oct 1, 2017, 00:00

  • Therapy Adherence in Asthma – Assessment of Potential Adherence Barriers

    Oct 1, 2017, 00:00

  • 6th LAC Abstracts - Financial Disclosure Statements

    Oct 1, 2017, 00:00

  • The Implementation Of Robotic-Assisted Surgery For Endometrial Cancer In The United States Lead To An Improvement Of Overall 30-Day Surgical Outcomes Without Increasing Costs- Is Technology Finally Allowing The Diffusion Of Minimally Invasi ...

    Oct 1, 2017, 00:00

  • One Year Report Card For The Cancer Drugs Fund Reforms – From Absurdity To Irrelevance?

    Oct 1, 2017, 00:00

  • Effect of Vitamins in Prevention of Alzheimer’s Development- A Meta-Analysis of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Estimating The Public Economic Impact Of Different Hepatitis C Healthcare Policies In The Netherlands

    Oct 1, 2017, 00:00

  • Will Prioritization of Vaccine Introduction Lead to a Higher Return of Investment? The Case of Colombia

    Oct 1, 2017, 00:00

  • Decision Making Clinical Scenarios As A Tool In HTA Process

    Oct 1, 2017, 00:00

  • Interrupted Time Series Analysis Evaluating The Impact of A Pro-Generic Policy on Drug Pricing and Utilization In Argentina

    Oct 1, 2017, 00:00

  • Bypassing Agents Prophylaxis In Patients With Haemophilia And Inhibitors Undergoing Surgery- A Decision Analysis In Spain

    Oct 1, 2017, 00:00

  • Denied Oncology Treatment Claims- How Much Do They Cost and How Can we Prevent Resource Waste?

    Oct 1, 2017, 00:00

  • Hierarchical Bayesian Model Accounts For Heterogeneity In Oncologists’ Stated Preference On Various Breast Cancer Treatments

    Oct 1, 2017, 00:00

  • Sensitive Skin In Fran Updated Epidemiological Data

    Oct 1, 2017, 00:00

  • Direct Medical Costs Of Hypoglycemia Hospitalizations In The United States

    Oct 1, 2017, 00:00

  • Self-Perceived Health in Latin America- Results from 2007-2008 Gallup World Poll

    Oct 1, 2017, 00:00

  • Vaccine Efficacy, Effectiveness, Or Impact- Which One To Choose In Economic Evaluations Of Vaccines?

    Oct 1, 2017, 00:00

  • Alcohol Use and Related Health Problems Among Ethiopian Adults in Gondar- A Cross Sectional Study

    Oct 1, 2017, 00:00

  • Cost Comparison of Licensed Intravitreal Therapies For Diabetic Macular Edema That Responds Insufficiently To Intravitreal Anti-Vegf – A German 3 Year Cost Model

    Oct 1, 2017, 00:00

  • Estimating Life Years And Quality-Adjusted Life Years In Heavily Treatment-Experienced (HTE) Patients

    Oct 1, 2017, 00:00

  • Budget Impact Of Introducing Ceftazidime-Avibactam (CAZ-AVI) For Complicated Intra-Abdominal Infection (CIAI), Complicated Urinary Tract Infections (CUTI), And Hospital Acquired Pneumonia Including Ventilator-Associated Pneumonia (HAP/VAP) ...

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Diagnosis- from Tests to Long-Term Outcomes and Costs

    Oct 1, 2017, 00:00

  • Translation And Cultural Adaptation Of The Body-Q Chest Module Into Finnish For Use In Gynecomastia, Weight Loss And FTM Chest Surgery

    Oct 1, 2017, 00:00

  • Misclassification of Diabetes Type I in German Claims Data

    Oct 1, 2017, 00:00

  • Methodological Issues With Key Drug Value Frameworks

    Oct 1, 2017, 00:00

  • The Arrival Of Therapeutic Biosimilars In Oncology- The Case Of Trastuzumab

    Oct 1, 2017, 00:00

  • Haart Treatment Trends In Hiv/Aids Patients In A Tertiary Care Hospital, Malaysia

    Oct 1, 2017, 00:00

  • Spatial Dynamics Of Psychiatric Disease Hospitalized Patients - Rehospitalization Simulation Focussing On Diabetes Comorbidity And Regional Health Services In Three European Regions Over The Next Decades

    Oct 1, 2017, 00:00

  • Real-World Utilization Of Blinatumomab In Acute Lymphoblastic Leukemia In The US

    Oct 1, 2017, 00:00

  • Costs And Life Expectancy Increased Among Patients With Breast Cancer Across Two Time Periods

    Oct 1, 2017, 00:00

  • BRCA1/2-Mutated Breast Cancer In Select EU Markets- Incidence, Treatable Populations, And Potential Market Size For Parp Inhibitors

    Oct 1, 2017, 00:00

  • Health Technology Assessment In Singapore- Shining A Light In The Darkness

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Avelumab in Patients with Metastatic Merkel Cell Carcinoma in The US

    Oct 1, 2017, 00:00

  • Plaque Psoriasis In Bulgaria- Comparative Analysis and Health Technology Assessment

    Oct 1, 2017, 00:00

  • Add-On Therapy in Breast Cancer - Probability of Cost-Effectiveness in Economic Analyses

    Oct 1, 2017, 00:00

  • Pulmonary Tuberculosis Trends and Treatment Outcomes In The Gomoa West District,Ghana

    Oct 1, 2017, 00:00

  • The Association Hemoglobin Levels with Health-Related Quality of Life of Patients with Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Health and Economic Benefits of Using Single Versus Multiple Inhalers in Patients with Asthma- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Estimations of Resource use, Costs, Clinical and Epidemiological Outcomes of Continuous and Intermittent Renal Replacement Therapies

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Mexico

    Oct 1, 2017, 00:00

  • The Effect Of Epilepsy On The Bulgarian Patients – Pilot Study

    Oct 1, 2017, 00:00

  • CYP2C19 Guided Antiplatelet Therapy- A Cost-Effectiveness Analysis of 30-Day and One-Year Outcomes Following Percutaneous Coronary Intervention

    Oct 1, 2017, 00:00

  • The Flow Of EU-28 Country Clusters In Terms Of Infectious And Chronic Diseases During A Refugee Crisis

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Hemostatic Matrix Pads VS Standard of Care In Cardiac Surgery (Italian Hospital Perspective)

    Oct 1, 2017, 00:00

  • Statin Cost Effectiveness- A Systematic Review Including The Recent Literature

    Oct 1, 2017, 00:00

  • The Comparative Performance of the CHU-9D and Adqol Amongst Children Aged 5 Years or More with Eczema- Evidence from the Clothes Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • Affordability and WTP Challenges of Combinations of High Value/High Priced Products In Oncology – Identifying Solutions for Immunotherapies, Precision Medicines, and Anti-Body Drug Conjugates

    Oct 1, 2017, 00:00

  • Municipal Health Conferences In The State Of Baden-Wuerttemberg, Germany – Ready For Initiating And Steering Primary Health Care Provisions At Community Level?

    Oct 1, 2017, 00:00

  • Access And Reimbursement For Emerging Neuropathic Pain Agents In The EU5- Avoiding The Sting Of Low-Cost Competition And Tightening Budgets

    Oct 1, 2017, 00:00

  • Baseline Population Characteristics And The Association Between Progression-Free Survival And Overall Survival In Advanced Non-Small Cell Lung Cancer Patients

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Vancomycin And Linezolid- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • The Modelled Effectiveness of Ruxolitinib on Survival in Polycythemia Patients with Hydroxyurea Resistance/Intolerance in Turkey

    Oct 1, 2017, 00:00

  • Cost Utility Analysis (CUA) of Nivolumab Compared To Everolimus for The Treatment of Metastatic Renal Cell Carcinoma (RCC) in Australia

    Oct 1, 2017, 00:00

  • Quality-Adjusted Life Year (QALY) Losses Associated With Herpes Zoster And Postherpetic Neuralgia In Immunocompromised (IC) and IC-FREE Individuals AGED ≥50 Years of Age, In The Uk Population

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of P4HB VS Permanent Synthetic Meshes In Complex Abdominal Wall Repair In Spain

    Oct 1, 2017, 00:00

  • Prescribing Pattern Along With Pharmacoeconomic Evaluation In Primary Health Care Facilities Nepal

    Oct 1, 2017, 00:00

  • Indicators to Evaluate Hiv Prevention in Colombian Health System

    Oct 1, 2017, 00:00

  • Epidemiology of BRAFV600-Mutated Metastatic Melanoma In Europe- A Systematic Review

    Oct 1, 2017, 00:00

  • The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic

    Oct 1, 2017, 00:00

  • Comparative Effectiveness of Venetoclax In View of A Clinical Trial With No Control Group

    Oct 1, 2017, 00:00

  • Health Economics Evidence in Peer-Reviewed Journals- Increase in Reporting of Real-World Data Over Time in Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Adherence To Treatment, Healthcare Resource Use And Costs Related To HIV Patients With Treated With

    Oct 1, 2017, 00:00

  • The Role Of Patient Groups In Nice Technology Appraisals For Drugs For Rare Diseases

    Oct 1, 2017, 00:00

  • Comparison of The Reimbursement Decisions of Pharmaceuticals In Hungary, Romania And Turkey

    Oct 1, 2017, 00:00

  • Comparison of U.S. Hospital Costs Between Transcatheter Aortic Valve Replacement (TAVR) And Surgical Aortic Valve Replacement (SAVR)

    Oct 1, 2017, 00:00

  • Different Methods for Modelling Severe Hypoglycaemic Events- Implications for Effectiveness and Cost-Effectiveness Analyses

    Oct 1, 2017, 00:00

  • Treatment Of Postpartum Depression- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Exploring The Burden of Illness and Impact of SQ-Standardised Grass Allergy Immunotherapy Tablet Treatment (AIT) on Quality of Life (QOL) in Patients with Allergic Rhinitis (AR) in Germany and The Netherlands

    Oct 1, 2017, 00:00

  • Antihypertensive Drug Treatment Prescribed for Essential Hypertension in a Private Hospital in South Sumatra, Indonesia

    Oct 1, 2017, 00:00

  • Validation Of The EQ-5D-5L In Patients With Hip Or Knee Osteoarthritis

    Oct 1, 2017, 00:00

  • No EQ-5D? Analysis of Alternative Utility Value Sources Used in Nice Appraisals for Oncology Indications

    Oct 1, 2017, 00:00

  • Understanding Mortality In Multiple Myeloma (MM)- Findings From An Observational Chart Review of Deceased Patients In The UK, France, Germany, Italy And Spain

    Oct 1, 2017, 00:00

  • The Effect of Policies for Improving the Access to New Medicines in South Korea- A Retrospective Analysis in 2007 - 2016

    Oct 1, 2017, 00:00

  • Budget Impact of A Supra-Ciliary Micro-Stent In Both Stand-Alone Surgery And In Combination With Cataract Surgery For Primary Open-Angle Glaucoma From A UK Secondary Care Perspective

    Oct 1, 2017, 00:00

  • Assessment of Patients Admitted For Drug-Related Problems In Cancer Chemotherapy

    Oct 1, 2017, 00:00

  • Idelvion For The Treatment of Hemophilia B- A Budget Impact Analysis In The Italian Setting

    Oct 1, 2017, 00:00

  • Evaluation of Health Care Reform Impact on Cancer Patients` Total out of Pocket- A Pilot-Center Experience in Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Public Health Expenditure In Patients With Non-Hodgkin's Lymphoma In Mexican Institutions

    Oct 1, 2017, 00:00

  • Orphan Drug Reimbursement In Europe- Do Less Stringent Regulatory Requirements Translate Into Less Favourable Reimbursement?

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Nivolumab for Patients with Advanced, Previously Treated Renal Cell Carcinoma in Scotland

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Adding New Drug Thiozonide To Iv-Th Drug Regimens For Multidrug-Resistant Tuberculosis

    Oct 1, 2017, 00:00

  • Patients’ Information Sources and Needs in Multiple Sclerosis- the Infoseek-MS Questionnaire

    Oct 1, 2017, 00:00

  • Close HER2 Home- Breast Cancer Patients Preferences For Treatment Delivery

    Oct 1, 2017, 00:00

  • Empirical Studies On The Economic Value Of A Statistical Life Year (VSLY) In Europe- What Do They Tell US?

    Oct 1, 2017, 00:00

  • Estimating Utilities / Disutilities for High Risk Metastatic Hormone-Sensitive Prostate Cancer (MHSPC) and Treatment-Related Adverse Events

    Oct 1, 2017, 00:00

  • Number of Visits Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013

    Oct 1, 2017, 00:00

  • Patient Characteristics of Premix Insulin Users in China- An Analysis of Electronic Medical Record Data

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Apixaban And Rivaroxaban For Treatment of Acute Venous Thromboembolism In China

    Oct 1, 2017, 00:00

  • Review Of Published Health-Economic Appraisals By The Haute Autorite De Sante (HAS) In Advanced Melanoma

    Oct 1, 2017, 00:00

  • Funding New Technologies in German Inpatient Care - Does it Work?

    Oct 1, 2017, 00:00

  • Characterization Of Worldwide Publications On Network Meta-Analysis- A Systematic Review

    Oct 1, 2017, 00:00

  • Health Insurance Cost of Psychotic Disorders In Hungary- A Cost of Illness Study

    Oct 1, 2017, 00:00

  • Determinants Of Herpes Zoster Vaccine Acceptability Among Older People In The UK

    Oct 1, 2017, 00:00

  • Economic Evaluation for The Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) From The NHS Perspective- A Spending Predictor Model for Italy, Romania and Spain

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Community Pharmacists' Intervention For Patients With Type 2 Diabetes In Prevention of Diabetic Retinopathy

    Oct 1, 2017, 00:00

  • Analysis Of Pharmacy Claims For High Cost Drugs- Ruxolitinib Utilisation And Expenditure In Ireland

    Oct 1, 2017, 00:00

  • Determinants Of The Optimal Route To Reimbursement For Orphan Medicinal Products (OMPS) In England

    Oct 1, 2017, 00:00

  • F-Calprotectin Use In Inflammatory Bowel Disease Is Characterised By Improved Diagnostic Accuracy, Less Patient Harm And Decreased Costs, Compared With Conventional Serological Markers And Colonoscopy. A Simulation Study In The Netherlands ...

    Oct 1, 2017, 00:00

  • Patient-Reported Outcome Measures for Women with Vulvodynia

    Oct 1, 2017, 00:00

  • Compras De Medicamentos Sem Licitação No Instituto Nacional De Câncer Do Brasil

    Oct 1, 2017, 00:00

  • Costo De La Atención De La Enfermedad De Crohn En Un Centro Asistencial De Bogotá, Colombia

    Oct 1, 2017, 00:00

  • Therapeutic Reference Pricing System Cost-Saving Ability And Its Impact On Patient Out-Of-Pocket Expenses In Slovenia

    Oct 1, 2017, 00:00

  • Comparative Effectiveness And Safety Of Medical Abortion For Second-Trimester Pregnancy Termination- A Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • The French Compassionate Program "Temporary Authorization For Use" And Thereafter... How Can It Affect Drug Market Access?

    Oct 1, 2017, 00:00

  • Resource Utilization And Disaggregated Cost Analysis For Initial Treatment Of Melanoma

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Effectiveness of the Inclusion of Glycopyrronium Bromide into the Program of Reimbursement of Essential Drugs for Patients with COPD

    Oct 1, 2017, 00:00

  • Key Factors Resulting In Differential Reimbursement Decisions Between The National Institute For Health And Care Excellence (NICE) And The Scottish Medicines Consortium (SMC) For Medicines Authorised By The European Medicines Agency (EMA) T ...

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Bariatric Surgery In Turkey- From A Long-Term Perspective

    Oct 1, 2017, 00:00

  • Comparison of Low-Dose Liraglutide Use Versus other GLP-1 Receptor Agonists In Patients Without Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Using A "Landmark" Approach To Artificially Populate The Comparator Arm Of An Economic Model Using Data From A Phase II, Uncontrolled Trial In Advanced Basal Cell Carcinoma

    Oct 1, 2017, 00:00

  • A Retrospective Analysis Of The Role Of (Economic) Evidence In Decision Making- The Introduction Of HPV Vaccination In The Netherlands

    Oct 1, 2017, 00:00

  • Epidemiology and Outcomes of Different Treatment Strategies In Patients With Pneumonia Caused By Carbapenem-Resistant Acinetobacter Baumnnii In Medical Intensive Care Units

    Oct 1, 2017, 00:00

  • Trabectedin Versus Pazopanib within The Treatment of Advanced, Metastatic, Leiomyosarcomas in Scotland- Results of A Cost-Effectiveness Analysis Following A Matching Adjusted Indirect Comparison

    Oct 1, 2017, 00:00

  • Inhibitors of Tirosin Kinasa in Chronic Mieloid Leukemia- Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Costs of Adding Sitagliptin or Sulphonylurea To Metformin- An Observational Study Using Administrative Database of Italy

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Trifluridine and Tipiracil Hydrochloride In The Treatment of Metastatic Colorectal Cancer in Greece

    Oct 1, 2017, 00:00

  • The Prescription Pattern and Prevalence of Psoriasis in a Tertiary Care Hospital

    Oct 1, 2017, 00:00

  • An Audit of Evidence Review Group Criticisms of Systematic Literature Reviews Conducted To Inform Manufacturers' Submissions To The National Institute for Health and Care Excellence

    Oct 1, 2017, 00:00

  • Costo De La Inmunización De Rutina En Menores De Un Año En El Año 2016 En El Ecuador

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns in Metastatic and/or Unresectable Gastric Cancer Patients. Preliminary Results From Colombia

    Oct 1, 2017, 00:00

  • Quimioterapia Do Câncer Nas Últimas Semanas De Vida- Estudo Retrospectivo Em Beneficiários De Um Plano De Saúde Privado No Brasil

    Oct 1, 2017, 00:00

  • The Short Term Health Related Quality Of Life (HRQOL) Impact On Patient At The Internal Medicine Clinic

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Obinutuzumab Associated to Chlorambucil for the Treatment of Slow-Go Patients with Chronic Lymphocytic Leukemia (CLL) Under the Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • The Association Between Disease Activity and Health-Related Quality of Life in RRMS Patients

    Oct 1, 2017, 00:00

  • Regulatory Reimbursement Decisions Database for Innovative Drugs to Improve Consistency of Decision-Making

    Oct 1, 2017, 00:00

  • Identifying a Claims-Based Definition of Satisfaction with Linaclotide Treatment Among Patients with Irritable Bowel Syndrome with Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC)

    Oct 1, 2017, 00:00

  • The Importance Of The Disinvestment Process In The Public Health System

    Oct 1, 2017, 00:00

  • Appropriate Diagnosis And Treatment As Key Elements To Improve Health And Rationalize Use Of Resources For Obsessive-Compulsive-Tic-Disorder

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Insulin Degludec U100 Compared With Insulin Glargine U100 In Greece

    Oct 1, 2017, 00:00

  • The Financial Burden of Diabetes Mellitus Type 1 And Type 2 In Egypt

    Oct 1, 2017, 00:00

  • What Impact Does Nice’s Modified Cancer Drugs Fund Process Mean For Patient Access To New Oncology Pharmaceuticals In England?

    Oct 1, 2017, 00:00

  • Heterogeneity In GP Consultation Costs In Health Technology Assessments- Explanations And Implications

    Oct 1, 2017, 00:00

  • Medical Treatments for Acromegaly- Systematic Review and Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Costo Y Consumo De Recursos De Pacientes Posterior A Enfermedad Cerebrovascular En Colombia

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Contour Curved Cutter Stapler In Low Anterior Resection In Turkey

    Oct 1, 2017, 00:00

  • Evaluating Patients’, Physicians’ And Pharmacists’ Perception Regarding Generic Medicines In Ethiopia- Findings And Implications

    Oct 1, 2017, 00:00

  • Minimizing Bias In Parametric Survival Analyses Of Published Kaplan-Meier Curves

    Oct 1, 2017, 00:00

  • Systematic Review of Cohort-Level Economic Models for Antipsychotics In Schizophrenia

    Oct 1, 2017, 00:00

  • The Cost Of Illness Of Heart Failure In Portugal

    Oct 1, 2017, 00:00

  • An Economic Evaluation Of 'Delivering Assisted Living Lifestyles At Scale’ (DALLAS)

    Oct 1, 2017, 00:00

  • Comparative Effectiveness Study Of A New Bayesian's Causal Inference Method

    Oct 1, 2017, 00:00

  • Is the Disconnect Between European Member State Controlled Compassionate Use Programs and the Centralised EMA Process Creating an Early Access Lottery for Patients?

    Oct 1, 2017, 00:00

  • Comparative Effectiveness of Rivaroxaban VS Vitamin K Antagonist In Routine Care Patients Treated For Non-Valvular Atrial Fibrillation In Germany – A Renal Impairment Subgroup Analysis

    Oct 1, 2017, 00:00

  • Valuing Health At The End Of Life- An Examination Of Framing Effects And Study Design Considerations

    Oct 1, 2017, 00:00

  • Adjusting for Treatment Switching in the Relapsing-Remitting Multiple Sclerosis Clarity Trial and the Clarity Extension Study

    Oct 1, 2017, 00:00

  • Market Share And Switching Dynamics Between Etanercept And Its Biosimilar Product In Sweden And Germany- A Real-World Preliminary Analysis

    Oct 1, 2017, 00:00

  • Overcoming the Limitations of Claims Data- Linkage of Claims Data with Secondary Data Sources in Germany

    Oct 1, 2017, 00:00

  • Economic Outcomes Of The Attune® Knee System- Analysis Of Real World Length Of Stay In An Italian Hospital

    Oct 1, 2017, 00:00

  • 12 Month Review of Nice and SMC Recommendations for New Technologies

    Oct 1, 2017, 00:00

  • Application Of Multi-Criteria Decision Analysis (MCDA) To Determine The Value Of Treatments For The Moderate To Severe Plaque Psoriasis In Spain

    Oct 1, 2017, 00:00

  • Management of Atherogenic Dyslipidemia in the Primary Care Settting in Spain

    Oct 1, 2017, 00:00

  • The Impact Of Modifying Factors On Icer For Pharmaceutical Reimbursement Recommendations In Korea Over 10 Years

    Oct 1, 2017, 00:00

  • EVALUATION OF SMOKING PREVALENCE AND ITS ASSOCIATED FACTORS AMONG THE DIABETICS IN PAKISTAN

    Oct 1, 2017, 00:00

  • Maternal Screening And Treatment For Group B Streptococcus (GBS) Are Associated With Non-Adherence To Guidelines, False-Negative Results And High Management Costs In The United Kingdom, Italy, France, Spain And Germany

    Oct 1, 2017, 00:00

  • Management Of Chronic Gout – A Delphi (CONSENSUS) Consultation Of UK-Based Clinical Experts

    Oct 1, 2017, 00:00

  • Subjective Financial Burden Among German Cancer Patients - Relationship Of The Patients’ Economic Situation And Subjective Distress

    Oct 1, 2017, 00:00

  • Estimating The Proportion of Patients Diagnosed with Allergic Rhinitis, at Risk of Developing Asthma

    Oct 1, 2017, 00:00

  • Assessment of Nurse's Knowledge, Attitude and Practice Regarding Hepatitis-B Infection in Tertiary Care Public Hospital in Quetta Pakistan

    Oct 1, 2017, 00:00

  • Risk Of Complications With Minimally Invasive Surgery In Liver Resection

    Oct 1, 2017, 00:00

  • A Real World Evidence (RWE) Approach To Characterising An Ultra-Rare Disease (URD) Cohort of Metastatic Uveal Melanoma (MUM) Patients Within National Health Service England (NHSE)

    Oct 1, 2017, 00:00

  • Adaptation of International Cost-Effectiveness Analyses To A Single Country - The Case of Bariatric Surgery Versus Conventional Treatment For Obesity And Overweight

    Oct 1, 2017, 00:00

  • Modelización Económica Del Ajuste Por Riesgo Del Gasto Sanitario Per Cápita Segun Morbilidad En La Comunidad Valenciana, España

    Oct 1, 2017, 00:00

  • Estudio De Costo Efectividad Del Factor De Coagulación Recombinante IX Unido A Proteina Fc Para El Tratamiento De La Hemofilia B En Chile

    Oct 1, 2017, 00:00

  • Medication Adherence and Risk of Hospitalization in Pulmonary Arterial Hypertension (PAH) Patients Treated with Endothelin Receptor Antagonists (ERAS) or Phosphodiesterase Type 5 Inhibitors (PDE5IS)

    Oct 1, 2017, 00:00

  • Work Productivity in HER2 Positive Breast Cancer- A Comparison of Patients Across Stages of Early and Metastatic Disease

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Long-Acting Parenteral Antipsychotic Drug Flufenazine In The Treatment of Schizophrenia In Russia- A Hospital Perspective

    Oct 1, 2017, 00:00

  • Cost Model for a New Acoustic Diagnostic AID to Rule Out Coronary Artery Disease

    Oct 1, 2017, 00:00

  • Effects of Improved Detection And Treatment of Atrial Fibrillation On Burden of Disease Caused By Stroke In Germany

    Oct 1, 2017, 00:00

  • How To Sample Ordered Parameters In Probabilistic Sensitivity Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Sequential Treatment Containing Crizotinib for Non Small Cell Lung Cancer (ALK+) Patients

    Oct 1, 2017, 00:00

  • Expected Value of Sample Information For Individual Level Simulation Models To Inform Stop/Go Decision Making By Public Research Funders- A Methodology for The Dafneplus Diabetes Education Cluster Rct

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Costa Rica

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Treatment Strategies Initiated at Different Stages of Liver Fibrosis for Japanese Patients with Chronic Hepatitis C Genotype 1

    Oct 1, 2017, 00:00

  • Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison- An Analysis Based on All Pivotal Phase 3 Clinical Trial Data

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nilotinib Versus Dasatinib for The Second-Line Treatment of Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (CML-CP), Resistant or Intolerant To Imatinib, in Frame of Russian He ...

    Oct 1, 2017, 00:00

  • A Cost-Of-Illness Analysis For Community Acquired Pneumonia In Greece

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Comparison Between Biobrane and Suprathel for Partial Thickness Burn Treatment for Austria

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis Of Shortened Direct-Acting Antiviral Treatment For Mild Chronic Hepatitis C Virus

    Oct 1, 2017, 00:00

  • Burden of Moderate to Severe Depression in the US Adult Population

    Oct 1, 2017, 00:00

  • Cross Border Reproductive Care- Profile and Incentives of Women Travelling to Greece for IVF Treatment

    Oct 1, 2017, 00:00

  • Cost-Of-Illness Analysis For Lymphoedema In A Regional Hospital In East Bohemia

    Oct 1, 2017, 00:00

  • Network Meta-Analysis of Hazard Ratios vs. Fractional Polynomials Approach in a Cost-Effectiveness Analysis Considering Advanced Gastric Cancer

    Oct 1, 2017, 00:00

  • Lack Of Standardized Methods For Handling Multiples Sources For Model Parameters- A Systematic Review

    Oct 1, 2017, 00:00

  • Assessing Criteria for Nice Recommendation With The Hst Programme

    Oct 1, 2017, 00:00

  • The Burden Of Ad In French Adult Patients- A Multicentric Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Overall Survival In Patients With Non-Small Cell Lung Cancer- A Comparison Of Clinical Trial Versus Real-World Outcomes Using A Propensity Score Reweighting Approach

    Oct 1, 2017, 00:00

  • Emergency Department Use Among Autosomal Dominant Polycystic Kidney Disease Patients In The US

    Oct 1, 2017, 00:00

  • International Reference Pricing Expands Reach in Leading Latin American Countries

    Oct 1, 2017, 00:00

  • Montecarlo Model As A Tool In Estimation of Economic Burden of A Disease Through The Prediction of Biological Characteristics of Tumor In Breast Cancer

    Oct 1, 2017, 00:00

  • Expanded Access To Pembrolizumab from Cost-Savings Generated by Biosimilar Filgrastim (BIOSIM-FIL) in The Prophylaxis of Chemotherapy-Induced (FEBRILE) Neutropenia (CIN/FN)- Simulation Study

    Oct 1, 2017, 00:00

  • Accumulated Treatment Cost of New Therapies in Multiple Myeloma- Comparing the Combination of Daratumumab, Bortezomib and Dexamethasone with Carfilzomib and Dexamethasone For WHO Have Received at Least One Prior Therapy in Brazil

    Oct 1, 2017, 00:00

  • Barriers To Management of Diabetic Eye Diseases In Turkey- Dr Barometer Survey

    Oct 1, 2017, 00:00

  • Identifying Cost Effective Methods of Health Technology Assessment for Developers – The Need for Fast and Frugal Evaluation

    Oct 1, 2017, 00:00

  • Clinical Effectiveness of Smoking Cessation Therapy During Pregnancy

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Detecting Arrhythmias With Insertable Cardiac Monitors (ICM) In Turkey

    Oct 1, 2017, 00:00

  • Search Of High Active And Low Toxic Newly Synthesized Derivatives Of Piperidine For Regional Anesthesia

    Oct 1, 2017, 00:00

  • Impact of Comorbid Critical Limb Ischemia And Diabetes on Healthcare Resource Use And Costs

    Oct 1, 2017, 00:00

  • Evaluation Of Resource Utilization Among Infants, Young Children And Elderly Patients Diagnosed With Rsv Infection In The United States

    Oct 1, 2017, 00:00

  • Comparing Cost-Effectiveness Of A Centralized Versus Decentralized Stroke Care System- Using Patient-Level Data To Estimate Short- And Longterm Effects

    Oct 1, 2017, 00:00

  • Price Analysis of HIV Antiretroviral Drugs Marketed In The United States (1987-2015)

    Oct 1, 2017, 00:00

  • The Equivalence Between The Malay And U.S. English Versions Of Rand 36-Item Health Survey 1.0

    Oct 1, 2017, 00:00

  • Health Care Utilization and Costs of Multiple Sclerosis Patients in the Netherlands- A Health Care Claims Database Study

    Oct 1, 2017, 00:00

  • Do Budget Impact Analyses For Screening Of Cancers Follow International Guidelines? A Systematic Review

    Oct 1, 2017, 00:00

  • Effect of Multiple Sclerosis on Work Productivity

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients Argentina

    Oct 1, 2017, 00:00

  • Lower Anterior Resection Surgical Complications In Colorectal Cancer Patients- Association With Length of Stay, Discharge To Institutional Care, And 90-Day Readmission

    Oct 1, 2017, 00:00

  • Frecuencia De Partos Por Cesáreas EN Cartagena, Colombia, 2006 - 2015

    Oct 1, 2017, 00:00

  • Patient Preferences In Italy- Health State Utilities Associated With Attributes Of Weekly Injection Devices For Treatment Of Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Aging Of Health Care Professionals In Hungary

    Oct 1, 2017, 00:00

  • Compendium Of Methods For Measuring Patient Preferences In Medical Treatment

    Oct 1, 2017, 00:00

  • Gasto Farmacéutico Ambulatorio Y Hospitalario En Pacientes Con Cáncer De Mama En La Comunidad De Valencia. Análisis De Lo Grupos De Riesgo Clínico 2014-2015

    Oct 1, 2017, 00:00

  • Metformin Extended Versus Immediate Release In Saudi Arabia- A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Burden of Diabetic Foot Ulcers in India- Evidence Landscape from Published Literature

    Oct 1, 2017, 00:00

  • DIABETES MELLITUS ADHERENCE TO CLINICAL FOLLOW-UP, BASED IN LOCAL GUIDELINES AND METABOLICAL OUTCOMES

    Oct 1, 2017, 00:00

  • Health Economic Evidence on Non-Pharmacological Interventions For Persons With Dementia- A Systematic Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Neonatal Screening With Pulse Oximetry For The Detection of Critical Congenital Heart Disease In Colombia, 2017

    Oct 1, 2017, 00:00

  • Use of Brentuximab Vedotin to Treat Hodgkin Lymphoma in a Private Sector Setting in Brazil

    Oct 1, 2017, 00:00

  • Health Care Utilization Associated With Polypharmacy In Patients With Multiple Sclerosis

    Oct 1, 2017, 00:00

  • Genotype and Liver Fibrosis Distribution Among Hepatitis C Patients in A Single Center in the South of Brasil- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Opioid Substitution Treatment In Republic of South Africa

    Oct 1, 2017, 00:00

  • INCORPORATION OF NEW MEDICINES BY THE BRAZILIAN HEALTHCARE SYSTEM´S NATIONAL COMMITTEE FOR HEALTH TECHNOLOGY INCORPORATION, 2012 TO JUNE/2016

    Oct 1, 2017, 00:00

  • 90-Day Mortality and Its Predictors In Women With Contralateral Hip Fracture After Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • Impacto Do Encaminhamento Precoce Para Cuidados Paliativos NA Utilização De Atendimentos De Emergência Por Pacientes Com Câncer Avançado

    Oct 1, 2017, 00:00

  • Is It Cost-Effective To Vaccinate Patients With Acute Coronary Syndrome Against Influenza Virus?

    Oct 1, 2017, 00:00

  • The Role Of Medical Technologies In Revolutionising The NHS In England- A Review Of Sustainability And Transformation Plans (STPS)

    Oct 1, 2017, 00:00

  • Economic Burden Of Herpes Zoster In Spain

    Oct 1, 2017, 00:00

  • Classification of Chronic Obstructive Pulmonary Disease (COPD) Severity According to the Global Initiative for Chronic Obstructive Lung Disease (Gold)- Variations in the Defintion of Gold Groups and Their Impact on Stage Assignment

    Oct 1, 2017, 00:00

  • Economic Burden Of Herpes Zoster (“CULEBRILLA”) In Latin America

    Oct 1, 2017, 00:00

  • Launching Combination Therapies In Rare Diseases- Is High Cost Burden Restricting Access?

    Oct 1, 2017, 00:00

  • Utility Elicitation for Allergic Rhinoconjunctivitis and Asthma in Children

    Oct 1, 2017, 00:00

  • LOS COSTOS Y SU INCIDENCIA EN EL USO DE LA POLIFARMACIA EN EL ADULTO MAYOR EN ECUADOR

    Oct 1, 2017, 00:00

  • Orthognacthic Surgery in Brazil- Mapping the Variability in Requested Matherials Using Real-World Data

    Oct 1, 2017, 00:00

  • Trends In Opioid Prescribing In Primary Care Patients With Knee Osteoarthritis- A Population Based Observational Study

    Oct 1, 2017, 00:00

  • Non-Persistence Risk And Health Care Resource Utilization of Italian Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Allowing Respondents To Skip Items During Electronic Collection Of Patient-Reported Outcome (PRO) Data- Does It Matter?

    Oct 1, 2017, 00:00

  • Applicability Of The EQ-5D-3L Descriptive System To Explore Subjective Future Health Expectations

    Oct 1, 2017, 00:00

  • Poor Outcomes Associated with Antithrombotic Potential Undertreatment in Patients with Atrial Fibrillation- A Retrospective Cohort Study

    Oct 1, 2017, 00:00

  • Assessment Of Innovative Medical Devices- Proving The Benefit For The Patient – Best Practices From Germany And France

    Oct 1, 2017, 00:00

  • Use Of The Ims Core Diabetes Model (CDM) In A Long-Term Projected Health Economic Comparison Of CSII And MDI Treatments Of Type 1 Diabetes (T1D) In A Newly-Diagnosed Population Of Paediatric Patients

    Oct 1, 2017, 00:00

  • A Systematic Literature Review On Quality Of Life And Economic Burden Of Psoriasis In The Asia-Pacific Region

    Oct 1, 2017, 00:00

  • Application Of Balancing Techniques In Studies Utilizing German Administrative Claims Data

    Oct 1, 2017, 00:00

  • Real-World Evidence on Clinical use of a Novel Oral Anticoagulant for the Treatment of Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Deciding On Universal Rotavirus Vaccination In The Netherlands - Again

    Oct 1, 2017, 00:00

  • Living With Chronic Diseases In Gree Investigating Health Services Utilization Patterns And Economic Consequences

    Oct 1, 2017, 00:00

  • Adequately Reflecting The Clinical Benefits In Rare Disease Economic Modeling Using Sma Type I As A Casestudy

    Oct 1, 2017, 00:00

  • Annual Economic Comparison of Prophylactic Treatment of Severe Haemophilia A In Spain

    Oct 1, 2017, 00:00

  • Importance Of Tendering After Patent Expiry In Germany

    Oct 1, 2017, 00:00

  • Burden of Cardiovascular Disease (CVD) For Patients With Familial Hypercholesterolemia (FH) Or Atherosclerotic CVD (ASCVD) And The Impact Of Low Density Lipoprotein-Cholesterol (LDL-C) Lowering In Two Middle East Countries

    Oct 1, 2017, 00:00

  • Requirements For A Novel Inhaled Combination To Improve Management Of Pseudamonas Aeruginosa Infections In Cystic Fibrosis Patients - A Payer Perspective

    Oct 1, 2017, 00:00

  • A Review of The Approaches Used To Model Subsequent Treatments In Nice Economic Evaluations- Examples Within Multiple Myeloma And Renal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Too Broad To Be Sensitive? Exploring The Responsiveness Of The Icecap-O Capability Wellbeing Measure Compared To The EQ-5D-3L To The Change Of Clinical And Qol Aspects In People With Parkinson’s

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Flash Glucose Monitoring System Based On Real-World Usage For Type 1 Diabetes (T1DM) Patients Using Intensive Insulin- A Swedish Perspective

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Same And Mixed Budesonide And Formoterol Inhalers In The Treatment of Asthma In Russian Federation

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK

    Oct 1, 2017, 00:00

  • Integrated Care Models In Germany – Potential Market Access Route For Medical Devices?

    Oct 1, 2017, 00:00

  • Potenciales Ahorros De La Implementación De La Prueba Dímero D (Point of Care) EN LA Atención De Primer Contacto De Pacientes Con Sospecha De Trombosis Venosa

    Oct 1, 2017, 00:00

  • Comparative Assessment of Latin American HTA Appraisals for Oncology

    Oct 1, 2017, 00:00

  • The Impact of Biosimilar Launch on Molecule Price and Pharmaceutical Expense- The Case of the Insulin Glargine in Italy

    Oct 1, 2017, 00:00

  • Prevalence of Obstructive Sleep Apnea in German In-Hospital Patients

    Oct 1, 2017, 00:00

  • Real World Characteristics and Perceived Efficacy of Peginterferon Beta-1A Compared with Other Platform Injectable Therapies Among MS Patients- Evidence in Five European Countries

    Oct 1, 2017, 00:00

  • Pooled Real World Databases Analysis of Patient’s Reported Outcomes In Rheumatoid Arthritis Patients

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Guided Internet-Based Treatments for Depression In Comparison With Control Conditions- An Individual-Participant Data Meta-Analysis

    Oct 1, 2017, 00:00

  • Impact Of Time To Reimbursement Of Drug Treatments For Non-Small Cell Lung On Patient Outcomes In Europe And Latin America

    Oct 1, 2017, 00:00

  • Randomized Controlled Trial Evaluating the Effectiveness of Pictogram Intervention in Identification and Reporting Adverse Drug Reactions in Naïve Hiv Patients in Ethiopia

    Oct 1, 2017, 00:00

  • Adherence Issues in Diabetes Treatment- How can Acceptance Measurement Help Understanding Patients’ Concerns and Working on Solutions?

    Oct 1, 2017, 00:00

  • Estimation of the Budget Saving Potential Due to the Introduction of an Etanercept Biosimilar (SB4) for the Treatment of Approved Adult Etanercept Indications in Belgium

    Oct 1, 2017, 00:00

  • Overall Survival (OS) Versus Progression-Free Survival (PFS)- Is There A Rational For Replacing One Outcome For The Other?

    Oct 1, 2017, 00:00

  • Rates Of Uptake Of Novel Agents In Cancer (Prostate, Melanoma, And Lung)- Considerations For Forecasting In Economic Evaluations

    Oct 1, 2017, 00:00

  • Prospective Observational Study on Spontaneous Reporting of Adr On Geriatric Population

    Oct 1, 2017, 00:00

  • Treatment Patterns And Resource Use Of Type 2 Diabetes Patients Managed On Insulin In England – Results Of A Delphi Panel

    Oct 1, 2017, 00:00

  • Assessing the Burden of Chronic Heart Failure on Patients in Colombia

    Oct 1, 2017, 00:00

  • Financiamiento De Enfermedades Huérfanas Y Raras EN Latinoamérica

    Oct 1, 2017, 00:00

  • Economic Burden on families of Children Receiving inpatient Care

    Oct 1, 2017, 00:00

  • Budget Impact Model of Point of Care Test for Patients Under Chronic Warfarin Therapy in Brazil

    Oct 1, 2017, 00:00

  • Quality of Life Among Patients with Diabetes Mellitus at King Abdulaziz University Hospital in Saudi Arabia

    Oct 1, 2017, 00:00

  • Atopic Dermatitis Is Associated With Poor Quality of Life In Adult Patients

    Oct 1, 2017, 00:00

  • Reduction of LDL-C Levels is Most Important - Patient Preferences for Drug Treatment Adjunct to LDL-C Apheresis in Severe Hypercholesterolemia

    Oct 1, 2017, 00:00

  • The Analysis of The Relation Between The Duration of Administrative Procedures And The Methodological Accuracy And Reviewability As Well As The Results of The Submitted Pharmacoeconomic Analyses

    Oct 1, 2017, 00:00

  • The Impact of Vaccination And Patient Characteristics on Influenza Vaccination Uptake

    Oct 1, 2017, 00:00

  • Formulações Lipídicas De Anfotericina B- Simulação De Custo Com Dados De Mundo Real

    Oct 1, 2017, 00:00

  • Secukinumab Shows Higher Symptomatic Improvement and Lower Cost Per Response vs. Adalimumab After One Year Treatment of Active Ankylosing Spondylitis- A Cost Per Responder Analysis from A Chilean Perspective

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario Comparando 2 Métodos De Screening De Cáncer De Cuello Uterino (CCU) EN EL Sector Privado De Argentina

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK

    Oct 1, 2017, 00:00

  • Divergence of Evaluation of Orphan Drugs Between Regulators and Payers- Implications For Patient Access In US And EU

    Oct 1, 2017, 00:00

  • Lessons Learned with Managed Entry Agreements in Portugal

    Oct 1, 2017, 00:00

  • Analysis of Recent Approvals of Immuno-Oncology Drugs Across England, Scotland, Germany And France

    Oct 1, 2017, 00:00

  • Benefit-Risk And Medical Costs of Rivaroxaban 20mg Versus Vitamin K Antagonists From A French Nationwide Cohort of 220,000 Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Knowledge, Attitudes and Perceptions of Ketamine Use by Medical Practitioners in South Africa

    Oct 1, 2017, 00:00

  • Validation of a Screening Tool (ICUSI QUESTIONNAIRE) for AF Patients Receiving Vitaminin K Antagonist Therapy

    Oct 1, 2017, 00:00

  • Bridging The Gap Between International Standards Of Quality Of Care And Practices In The Inpatient Unit Of The National TB Control Center In Armenia

    Oct 1, 2017, 00:00

  • Therapeutic Strategies Utilization and Resources Consumption in Patients Treated for Psoriatic Arthritis in Italy

    Oct 1, 2017, 00:00

  • What Is The Scope And Quality of Economic Evidence Available for Atopic Eczema? A Systematic Review

    Oct 1, 2017, 00:00

  • Regional Distribution of The Most Common SPA Services In Hungary In 2014

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77 (current)
  • 78
  • 79
  • 80
  • »